Health Archive » February, 2011

Health - February, 2011

220 articles

• Calif. High Court Revives Baycol Class Action
• High Court Grapples With Gov't-Funded Patent Rights
• 5th Circ. Vacates FDA Win On Compounded Drug Review
• Medicis, Teva Resolve Solodyn Patent Suit
• Texas AG Probes Hospital Chain Over Medicaid Fraud
• Fed. Circ. Won't Rehear Merck Temodar Patent Case
• Elan, Abbott End Ranbaxy Suit Over Generic TriCor
• Fujifilm To Buy 2 Merck Biotech Units For $490M
• Obama Supports Bumping Up Health Care Waiver Date
• Femina Hits Merck, Pharmacies With NuvaRing 337 Suit
• J&J Can't Shake Omnicare FCA Claims
• PDL Settles Novartis IP Row With Lucentis Payments
• New HIPAA Obligations For The Financial Industry
• Humana Wins Back $24B Tricare Contract
• Cephalon, Cima Sue Mylan To Block Generic Fentora
• It's A Raid! Now What?
• High Court Leaves FLSA Status Of Drug Reps Up In Air
• US Wins Fight Over $15M Drug Testing Contract
• FTC Fails To Stay $58M LabCorp Merger
• Wachtell Reps Ventas In $17B Health Real Estate Deal
• Plaintiffs To Appeal Sack Of PPACA Religious Protest
• Synnex, Allscripts Ran Medical Software Market: Suit
• Texas Hospital Settles DOJ Antitrust Row
• 8th Circ. Kills Medicare Paybacks For 2 Hospitals
• Lilly To Pay Up To Resolve Air Emissions Suit
• Mylan Claims Fall In IP Suit Over Generic Azilect
• Bayer Sues Hexal, Salutas Over Heartburn Pill Patents
• Nurse Asks Supreme Court To Nix 9th Circ. OT Ruling
• Health Net FLSA Action Wins Conditional Class Cert.
• Elan Hid Problem With $1B J&J Deal, Investors Say
• Caraco Denied Quick Win On Prandin IP Misuse Claim
• Sandoz Hit With Patent Suit Over Skin Condition Drug
• Health Care Co. Blasts Rival For Talent, Client Theft
• Celgene Strikes $78M Deal In Elan Abraxane IP Suit
• FDA Grants Avastin Safety Hearing For Genentech
• Fed. Circ. Reverses Radiation Therapy Patent Ruling
• Former Employee Accuses J&J Of Drug Price Fraud
• Mylan Faces Patent Suits Over Generic Estradiol
• Beckman Investor Sues To Block $6.8B Danaher Deal
• Genetic Research Co. Loses Patent License Appeal
• FDA Outlines Initiatives Inspired By DES 'Tragedy'
• Fed. Circ. Affirms Siemens' $45M Scanner Patent Win
• Challenging Obama's Health Care Plan
• Researcher Sues CVS For Prescription Data
• Endo Can't Shake Claims In Roche Generic Valcyte Suit
• WilmerHale Reps Thermo Fisher In $940M Unit Sales
• Medicines Co. Sues Mylan Over Generic Angiomax
• Nova Contract Claims Nixed Again In Roche IP Suit
• Genentech Used IP To Form $1B Monopoly, HGS Says
• Insurer Should Cover Workers' Comp Trust Suit: Judge
• House Urges FDA To Find Contaminated Heparin Source
• Latham Reps Silverfleet In $675M Sterigenics Sale
• GAO Denies Protest Over Navy Hospital Contract
• Fed. Circ. Knocks Down $1.7B Humira Patent Verdict
• Booted Union Head Sues SEIU For 'Cruel' Harassment
• NY Nets $2.5M In Settlement With Pfizer Subsidiary
• APS Healthcare To Pay $13M To Resolve Ga. FCA Suit
• Judge Tosses Religious Challenge To Health Care Act
• FTC Appeals Injunction Bid For $58M LabCorp Deal
• Ex-CEO Stole Trade Secrets, Drug Co. Says
• Bayer Vitamin False Ad Action Gets Trimmed
• Roxane Agrees To Delay Launch Of Generic Asacol
• Onex Exerted Undue Influence On $3B EMS Deal: Suit
• Pfizer Ends Suits Over Nigerian Trovan Deaths
• Philips Reports Possible FCPA Violations
• Sun Pharma Buys Out Remainder Of Caraco
• High Court Won't Review $5B Vioxx Deal
• Shareholders Sue EMSC Over $3.2B Deal
• Ex-Bristol Myers Worker Gets Time Served For IP Theft
• High Court Says Vaccine Act Preempts State Law Claims
• Covington Reps Forest Labs In $1.2B Clinical Data Deal
• Chem Rx Claims Former Exec Lured Clients To Rival
• FCA Liability In A Post-PPACA World
• Covidien Faces Class Action Over Off-The-Clock Work
• Zimmer Hits Law Firms With False Advertising Suit
• 11th Circ. Upholds Helvetia Fraudster's Conviction
• 7th Circ. Revives Chiropractor's FCA Suit
• HHS Whittles Health Care Conscience Statute
• Watson's Generic Mucinex Doesn't Infringe, Judge Says
• US Wants States To Follow Health Law Amid Appeal
• Biovail Founder Strikes Deal In SEC Fraud Suit
• Abbott Hits Sandoz With New Niaspan Patent Suit
• NZ Bans Avandia Over Cardiovascular Concerns
• Taming The Wild West Of IP Protection
• Sanofi Wins Injunction In Sun IP Suit Over Eloxatin
• Feds Charge 114 In Massive Medicare Fraud Crackdown
• Ex-Tenet Workers Can't Bag Class Cert. In Calif. Appeal
• House Republicans Blast Health Care Waivers
• Judge Disses Class Cert. Bid In Sanofi Ketek Suit
• Volcano Ordered To Pay $5M In LightLab Laser Fight
• Senate Bill Aims To Restrict Authorized Generics
• FDA Issues Recall Of Medtronic Infusion Pumps
• RehabCare CEO Cheated Investors In Kindred Deal: Suit
• Abbott, Fournier Drop Suit Over Generic TriCor
• Class Action Over Guidant Pacemakers Nixed
• PDL To Pay MedImmune $93M In IP Suit Over Synagis
• La. Seeks $12B In Avandia Medicaid Fraud Suit
• J&J Unit Recalls Antipsychotic Syringes Over Cracks
• Leo Pharma Sues Perrigo Israel Over Generic Taclonex
• Novo Nordisk Faces Criminal Probe Over Diabetes Drugs
• Reinsurer Off Hook For United Health's $28M Claim
• Health Care Law Cripples Federalism, Va. AG Says
• Brothers Plead Guilty To Insider Trading At Sequenom
• Sanofi Bags Genzyme With Incentive-Laden $20B Offer
• Favoring Policy Provision Over State Statute
• Health Reform Opt-Out Bill Moves Ahead In Tenn.
• House Committee Backs Bill Blocking Abortion Funding
• Quigley To Meet Deadline Or Face Asbestos Claims
• Valeant Must Share In Lilly Defense Costs, Judge Says
• High-Risk Recalls Have Weaker Approval Process: Study
• Inspire Settles AzaSite False Marking Suit
• Q-Med Pays To Shut Down Genzyme Injection IP Fight
• $3.6M Hemispherx Securities Settlement Gets Final OK
• PIC Loses Claim Construction Bid In DNA Patent Suit
• Recalled Triad Products Blamed For Child's Death
• Drug Sales Reps Exempt From OT, 9th Circ. Rules
• Bowman Expands Pharma Practice In New Austin Office
• Obama Takes Aim At Pay-For-Delay In 2012 Budget
• Argentum Must Pay $3M In Bandage Patent Suit: Jury
• Merck Wins 1st State Fosamax Trial In NJ
• Foreign Physiotherapists Can Take Exams In Ga.: Judge
• The Erosion Of W.Va.'s Borrowing Statute?
• Debevoise Reps Clayton Dubilier In $3.2B EMS Deal
• Fed. Circ. Won't Reinstate Lapsed University Patent
• NC Dental Board Fails To Take Bite Out Of FTC Case
• GAO Denies CGI's Protest Over $230M CMS Contract
• Senate Bill Would Ease Drug Imports, Boost Inspection
• Fed. Circ. Won't Rescue Hako-Med Patent Verdict
• MoFo Snags 2 Attys From Alston, Wilson Sonsini
• CORRECTED: Judge Won't Revisit GE's Liability In MRI Patent Suit
• GAO Tosses ACS Protest Over $142M DOL Contract
• Pharma/Device Enforcement: A Year In Review
• AstraZeneca Targets Korean Co. Over Nexium Patents
• Sun Pharma Freezes Generic Eloxatin Sales
• Novartis Says Mylan Infringed Lescol Patent
• Judge Approves Blood Plasma Antitrust MDL
• Calif. Appeals Court Lets J&J Motrin Suit Proceed
• Q-Med Board Endorses Galderma's Sweetened Bid
• Squire Sanders Adds Jones Day Life Sciences Atty
• ArthroCare Strikes Deal To End SEC Accounting Probe
• Omnicare V. UnitedHealth And Independent Action
• Sunshine Bill Aims To Restrict Court Secrecy Orders
• Cleveland Hospital Exec Gets 9 Years For Bribery
• Elan Shareholder Suit Gets The Boot
• Lilly Asks High Court To Review Double Patenting
• Thomas Recusal Unlikely In High Court Health Care Row
• EU Court Revives Ineos Bid For AlphaRen Mark
• Fed. Circ. Expands Fees Factors For Vaccine Cases
• House GOP Calls For Deep FY 2011 Budget Cuts
• The 'New Normal' In ESI Preservation Duties: Part 2
• DLA Piper Lures 2 Paul Hastings Litigation Leaders
• King & Spalding Lands 14-Lawyer Filice Brown Team
• J&J, Plaintiffs Seek Arbitration In Sutures MDL
• 6th Circ. Fast-Tracks Health Care Reform Fight
• JPML Won't Combine Boehringer Sales Reps' OT Suits
• Edwards Keeps $74M Award In CoreValve Patent Suit
• Pfizer Appeals Sanctions In Neurontin Antitrust Action
• UMass Gets Unfair Enrichment Claim Nixed In IP Suit
• NC Dental Board Not Immune From Antitrust Law: FTC
• Galderma's $978M Bid Falls Short With Q-Med Investors
• FDA To Fast-Track High-Tech Medical Devices
• State Health Care Waiver Bill Advances In Senate
• Pa. Court Reinstates $10M Verdict In Prempro Suit
• Natco Challenges Gilead Science's Tamiflu Patent
• Ariz. Hospitals Sue Coppersmith Over Antitrust Misstep
• Judge Orders 2 More Bellwethers In Fosamax MDL
• UCB To Pay PDL $10M Over Antibody Patents
• Square Peg, Round Hole: Product Defects And The FCA
• Attorneys Seek $22M In Fees For Pfizer Settlement
• Cleary Gottlieb Reps Kindred In $1.3B RehabCare Buy
• Ex-GSK Atty Wants Obstruction Charge Nixed
• 21 Governors Back Health Insurance Exchange Changes
• United, Workers Win Initial OK For $1.25M OT Deal
• 9th Circ. Shuts Down Sequus Medical Licensing Spat
• Judge Pushes To Nix 215 Plaintiffs In Neurontin MDL
• Cell Therapeutics Fails To Nix Investor Class Action
• GSK Tightens Avandia Restrictions
• Wachtell Reps Danaher In $6.8B Beckman Coulter Deal
• No New Trial For Bard In Hernia Patch Bellwether
• Constitutional Challenges To Health Care Reform
• Premera Offers $1.5M To End Tech Support FLSA Suit
• High Court Will Likely Let Health Care War Play Out
• Miss. Class Action Over Health Care Reform Law Nixed
• MDL Panel Won't Consolidate Infested Formula Actions
• B&B Challenges Terms Of VA Oxygen Services Contract
• Fried Frank Reps DaVita In $690M DSI Renal Deal
• Investors Sue NHI Over Nursing Home Sales Fraud
• Health Net Hits Solvay With AndroGel Antitrust Action
• States Can Cut Costs Without Medicaid Waivers: HHS
• Ex-Home Diagnostics CEO Indicted Over Stock Tips
• 3 Staffers Hit Hologic With Overtime Action
• UnitedHealth Wants GSK Paxil Case Back In State Court
• Investors Slam MannKind After FDA Balks On Afrezza
• Lupin Sues Paddock Over Generic Antara
• GOP Reps. Investigate $1.4B HHS 'Slush Fund'
• Va. Asks High Court To Review Health Care Law Now
• Case Study: White V. Wyeth
• Somaxon Hits Par With IP Suit Over Silenor Generic
• Metabolite Can't Have Cake, Eat It Too: 10th Circ.
• Senate Rejects Health Care Reform Repeal
• CareCore To Drop Radiologist Owners In NY AG Pact
• Australian Judge Allows Sale Of Generic Taxotere
• US To Join FCA Action Against Abbott Over Depakote
• Experts Spar On Legality Of Health Care Reform Law
• ITC To Investigate Birthing Dolls From China
• Watson Settles Androderm False Marking Suit
• Sens. Want More Studies Of Chromium-6 Levels
• NC Dental Board Says FTC Overstepped Powers
• Avastin Plus Chemo Equals Higher Death Risk: Study
• Actavis Ordered To Pay $170M In Medicaid Fraud Suit
• The 'New Normal' In ESI Preservation Duties: Part 1
• Health Care Ruling Raises New Question For High Court
• Pa. Hospital Antitrust Suit Stayed For High Court
• Genzyme Seeks Toss Of Investors' Insider Trading Suit
• Wyeth Loses Bid To Stay Stent Patent Dispute
• Health Centers Sue W.Va. Over Medicaid Payments
• Thoughts On The 2011 State Of The Union
• Health Care Co. Strikes $26M Deal In Medicaid Suit
• Drug Co. Valeant To Snap Up PharmaSwiss For $484M
• Direct Purchasers' Plavix Antitrust Actions Tossed